Aromatase inhibitors

Intervention1 paper1 finding

Humans1

Associations

1

Dyslipidemia

upin humans1Low certainty

1 study

Aromatase inhibitors raise the risk of dyslipidemia in humans (absolute CI difference = 6.84% (95% CI: 1.76-11.9)).
Humans5 yearsfemales
Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer · JNCI cancer spectrum · 24 Sep 2026

Dyslipidemia →

Latest

1

JNCI Cancer SpectrumHumans26 Sep

Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer